Fulveject 250 mg/5 ml solution for injection (fulvestrant, pre-filled syringe, 5 ml)    

Fulvestrant belongs to the group of estrogen blockers. Estrogens, a type of female sex hormones, can in some cases be involved in the growth of breast cancer.

Fulveject is used to treat advanced or metastatic breast cancer in postmenopausal women.